The p38 pathway: from biology to cancer therapy
A Martínez-Limón, M Joaquin, M Caballero… - International journal of …, 2020 - mdpi.com
The p38 MAPK pathway is well known for its role in transducing stress signals from the
environment. Many key players and regulatory mechanisms of this signaling cascade have …
environment. Many key players and regulatory mechanisms of this signaling cascade have …
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
HB Park, KH Baek - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
The mitogen-activated protein kinase (MAPK) signaling pathway is the primary regulatory
module of various cellular processes such as cell proliferation, differentiation, and stress …
module of various cellular processes such as cell proliferation, differentiation, and stress …
Clinical development of targeted and immune based anti-cancer therapies
NA Seebacher, AE Stacy, GM Porter… - Journal of Experimental & …, 2019 - Springer
Cancer is currently the second leading cause of death globally and is expected to be
responsible for approximately 9.6 million deaths in 2018. With an unprecedented …
responsible for approximately 9.6 million deaths in 2018. With an unprecedented …
FMS-like tyrosine kinase 3/FLT3: from basic science to clinical implications
JU Kazi, L Rönnstrand - Physiological reviews, 2019 - journals.physiology.org
FMS-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that is expressed almost
exclusively in the hematopoietic compartment. Its ligand, FLT3 ligand (FL), induces …
exclusively in the hematopoietic compartment. Its ligand, FLT3 ligand (FL), induces …
Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches
P Kusirisin, SC Chattipakorn, N Chattipakorn - Journal of Translational …, 2020 - Springer
Contrast-induced nephropathy (CIN) or contrast-induced acute kidney injury (CI-AKI) is an
iatrogenic acute kidney injury observed after intravascular administration of contrast media …
iatrogenic acute kidney injury observed after intravascular administration of contrast media …
[HTML][HTML] Targeted therapy for patients with BRAF-mutant lung cancer results from the European EURAF cohort
O Gautschi, J Milia, B Cabarrou, MV Bluthgen… - Journal of Thoracic …, 2015 - Elsevier
Introduction Approximately 2% of lung adenocarcinomas have BRAF (v-Raf murine sarcoma
viral oncogene homolog B) mutations, including V600E and other types. Vemurafenib …
viral oncogene homolog B) mutations, including V600E and other types. Vemurafenib …
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule …
A major challenge in cancer treatment is predicting the clinical response to anti-cancer
drugs on a personalized basis. The success of such a task largely depends on the ability to …
drugs on a personalized basis. The success of such a task largely depends on the ability to …
The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer
Z Siprashvili, DE Webster, D Johnston, RM Shenoy… - Nature …, 2016 - nature.com
Small nucleolar RNAs (snoRNAs) are conserved noncoding RNAs best studied as
ribonucleoprotein (RNP) guides in RNA modification,. To explore their role in cancer, we …
ribonucleoprotein (RNP) guides in RNA modification,. To explore their role in cancer, we …
Everything old is new again: drug repurposing approach for non-small cell lung cancer targeting MAPK signaling pathway
Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts
for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85 …
for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85 …
The upregulation of PI3K/Akt and MAP kinase pathways is associated with resistance of microtubule‐targeting drugs in prostate cancer
Z Liu, G Zhu, RH Getzenberg… - Journal of cellular …, 2015 - Wiley Online Library
Resistance is a significant limitation to the effectiveness of cancer therapies. The PI3K/Akt
and MAP kinase pathways play important roles in a variety of normal cellular processes and …
and MAP kinase pathways play important roles in a variety of normal cellular processes and …